Life-Time Risk, Screening and The Cost of Cardiovascular Comorbidities in CKD Patients

Insights

Chronic kidney disease (CKD) poses a significant public health risk, comparable to heart attacks. Addressing the economic impact of CKD-related cardiovascular issues is crucial for effective prevention strategies.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health
  • Health Economics

Background:

  • Chronic kidney disease (CKD) is a widespread health issue with epidemic proportions.
  • CKD patients face a mortality and cardiovascular complication risk equivalent to myocardial infarction.
  • The economic burden of cardiovascular comorbidities in CKD patients is substantial.

Purpose of the Study:

  • To highlight the significant economic impact of cardiovascular comorbidities in CKD patients.
  • To emphasize the need for cost-effectiveness studies on preventive interventions for CKD.
  • To call for research into reducing CKD risk and associated cardiovascular complications.

Main Methods:

  • Epidemiological data analysis from the MONICA-Augsburg study.
  • Cost analysis of myocardial infarction from a German health insurance company.

Main Results:

  • Cardiovascular comorbidities in CKD patients represent a substantial economic burden in Germany.
  • CKD is a "risk equivalent" for death and cardiovascular complications compared to myocardial infarction.

Conclusions:

  • The substantial economic burden of CKD-related cardiovascular issues necessitates further investigation.
  • Cost-effectiveness studies of preventive interventions are crucial for managing CKD and its complications.
  • Findings may be applicable to other large European Union member states.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
890
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
563
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
581
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
971
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K